Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Compass (COMP) Q4 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Feb 18, 2025
COMP earnings call for the period ending December 31, 2024.

Compass (COMP) Q3 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Oct 31, 2024
COMP earnings call for the period ending September 30, 2024.

Down 79%, This Growth Stock Could Double in the Housing Rebound
Jeremy Bowman
|
Aug 11, 2024
A recovery in the housing market could help revive the real estate industry.

Compass (COMP) Q2 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Jul 31, 2024
COMP earnings call for the period ending June 30, 2024.

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
Eric Volkman
|
May 9, 2024
The company has great potential if and when it enters the commercial stage.

Compass (COMP) Q1 2024 Earnings Call Transcript
Motley Fool Transcribing
|
May 9, 2024
COMP earnings call for the period ending March 31, 2024.

1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
Alex Carchidi
|
Mar 7, 2024
The company now has a chance to get its lead program out the door a bit sooner.

1 Beaten-Down Stock With 55% Upside, According to Wall Street
Prosper Junior Bakiny
|
Mar 4, 2024
The biotech has bounced back some in the past year.

Why Editas Medicine Stock Soared as Much as 42% Higher This Week
Danny Vena
|
Mar 2, 2024
The clinical-stage genome editing company dropped a couple of important announcements for shareholders.

Compass (COMP) Q4 2023 Earnings Call Transcript
Motley Fool Transcribing
|
Feb 27, 2024
COMP earnings call for the period ending December 31, 2023.

View More Articles